CSI Market
Sign In | Register

Karyopharm Therapeutics Inc (KPTI) Annual Balance Sheets

Annual · GAAP · USD millions
Access KPTI quarterly Balance Sheets →
This page allows investors to track Karyopharm Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent60.54
Restricted Cash and Cash Equivalents, Current0.00
Available-for-sale Securities, Debt Securities, Current MA3.20
Cash & Short-term Investments63.00
Accounts receivable26.18
Inventories4.04
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.19
Total Current Assets103.15
Equipment/Property/Plant Net0.10
Long-term investments0.35
Other Assets, Noncurrent5.17
Operating Lease Right Of Use Asset4.55
Total Assets108.42
Liabilities
Accounts Payable, Current AC4.00
Accrued Liabilities, Current AC64.50
Secured Debt, Current LO21.01
Other Liabilities, Current2.55
Total Current Liabilities92.06
Long-term debt94.80
Secured Debt94.80
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt94.80
Other liabilities, Noncurrent214.49
Operating Lease Liability Current0.97
Convertible Senior Notes Due Two Thous and Twenty Five-
Convertible Senior Notes Due Two Thous and Twenty Nine89.97
Operating Lease Liability Noncurrent5.74
Total Liabilities401.34
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,466.49
Retained Earnings / Accumulated Deficit-1,759.50
Other Equity0.07
Common Stockholder's Equity-292.93
Total Stockholder's Equity-292.93
Liabilities & Stockholder's Equity108.42
4 historic quarters locked

Sign in to unlock the full Karyopharm Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Karyopharm Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: kpti-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-049397

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License